Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nektar Therapeutics (NQ: NKTR ) 1.250 +0.060 (+5.04%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nektar Therapeutics < Previous 1 2 3 4 5 Next > NKTR Stock Earnings: Nektar Therapeutics Misses EPS, Beats Revenue for Q2 2024 August 08, 2024 NKTR stock results show that Nektar Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace NKTR Stock Earnings: Nektar Therapeutics Meets EPS, Beats Revenue for Q1 2024 May 09, 2024 NKTR stock results show that Nektar Therapeutics met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session May 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 30, 2024 Via Benzinga Sweet Nektar? April 22, 2024 NKTR has had a terrible time of it for years, but maybe it’s finally ready to turn around. Via Talk Markets Nektar Therapeutics Earnings Preview March 01, 2024 Via Benzinga Recap: Nektar Therapeutics Q3 Earnings November 07, 2023 Via Benzinga A Preview Of Nektar Therapeutics's Earnings November 06, 2023 Via Benzinga Expert Ratings for Nektar Therapeutics May 10, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session April 11, 2024 Via Benzinga Biotech's Lawsuit With Eli Lilly Might Catalyze Stock March 29, 2024 Nektar Therapeutics commenced a Phase 2b clinical trial evaluating its lead product candidate rezpegaldesleukin, in patients with severe to very severe alopecia areata, a disease-causing patchy hair... Via Talk Markets Topics Lawsuit Exposures Financial Legal Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 04, 2024 Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its... Via Benzinga Nektar Therapeutics: Q1 Earnings Insights May 09, 2023 Via Benzinga Analyst Ratings for Nektar Therapeutics March 06, 2023 Via Benzinga Earnings Scheduled For March 4, 2024 March 04, 2024 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter. Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session January 12, 2024 Via Benzinga The One-Minute Market Report - Saturday, Aug. 12 August 12, 2023 In this weekly outlook, I examine the asset classes, sectors, and ETFs that led the market higher, and which market segments bucked the trend by moving lower. Signs that market participation is... Via Talk Markets Topics ETFs 12 Health Care Stocks Moving In Tuesday's After-Market Session August 08, 2023 Via Benzinga Nektar Therapeutics Earnings Perspective: Return On Capital Employed March 06, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session August 07, 2023 Via Benzinga Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session August 07, 2023 Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of... Via Benzinga Why Is Nektar Therapeutics Stock Surging Today? August 07, 2023 Nektar Therapeutics Inc (NASDAQ: NKTR) said its former partner Eli Lilly And Co (NYSE: LLY) had presented "erroneous data" from two Phase 1b studies of its atopic dermatitis drug, Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session August 07, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023 May 10, 2023 Via Benzinga Tempur Sealy International To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Wednesday May 10, 2023 Keybanc raised the price target for Tempur Sealy International, Inc. (NYSE: TPX) from $48 to $50. Keybanc analyst Bradley Thomas maintained an Overweight rating. Tempur Sealy International shares rose... Via Benzinga Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions April 18, 2023 Via Benzinga 7 Sorry Pharma Stocks to Sell in April Before It’s Too Late April 16, 2023 You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards. Via InvestorPlace Analysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials April 13, 2023 This month, H.C. Wainwright & Co. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 21, 2023 On Tuesday, 74 companies achieved new lows for the year. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 14, 2023 Tuesday's morning session saw 84 companies set new 52-week lows. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.